Stockreport

Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study [Yahoo! Finance]

Can-Fite Biopharma Ltd Sponsored ADR (Israel)  (CANF) 
NASDAQ:AMEX Investor Relations: ir.canfite.com
PDF RAMAT GAN, Israel, June 05, 2024 BUSINESS WIRE )--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary [Read more]